Alliance Pharmaceuticals Limited
Martin Sutherland has a diverse work experience spanning various industries and roles. Martin has held executive positions in notable organizations such as XPS Pensions Group, Logiq Consulting, Alliance Pharmaceuticals Limited, and Forterra PLC, where they served as a Non-Executive Director. Additionally, they were the Chief Executive Officer of Reliance Cyber and De La Rue, which is the world's largest commercial banknote printer and passport manufacturer. Prior to these roles, Martin held positions at BAE Systems Applied Intelligence, Detica, BT, and Accenture, gaining expertise in systems engineering and consulting.
Martin Sutherland completed their MA in Physics at the University of Oxford from 1987 to 1990. Martin then pursued an MSc in Remote Sensing at UCL from 1994 to 1996.
This person is not in any teams
This person is not in any offices
Alliance Pharmaceuticals Limited
1 followers
We are Alliance Pharma plc, an international healthcare group. Our purpose is to improve the lives of consumers and patients, through making available a range of clinically valuable healthcare products. Headquartered in the UK, we employ more than 250 people based in locations across Europe, North America, and the Asia Pacific region. Our core focus is on the marketing of Consumer Healthcare brands. We also have a smaller Prescription Medicines business, which operates alongside this. In total, we hold marketing rights to around 80 brands, with our revenues being generated from a mix of direct, distributor and e-commerce sales. With annual revenues in excess of £160m, good margins and strong cash generation, we’re financially successful and have a strong appetite for growth. Outsourcing all of our manufacturing and logistics activities allows us to remain asset-light and to focus on leveraging the operating platform we’ve built across EMEA, AMER and APAC, in order to maximise the value and reach of our brands. For more information on Alliance, please visit our website: www.alliancepharmaceuticals.com Adverse Event Reporting Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Pharmacovigilance at Alliance Pharmaceuticals (tel: 01249 466966, email: pharmacovigilance@alliancepharma.co.uk)